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Summary.-A micro-assay designed to assess the capacity of peripheral blood
mononuclear cells to differentiate in vitro into mature macrophages is described. In
patients with "final common pathway" malignant melanoma, there was a highly
significant deficiency in macrophage precursors (MPs). By conventional morpho-
logical criteria such patients did not show a significant monocytopenia. Serum
factors do not seem to contribute to the MP defect in the patients. We conclude that
these patients have an intrinsic functional defect in their peripheral blood mono-
cytes, but the mechanisms responsible for this defect are as yet unknown.
CONTEMPORARY studies ofhostresponses
to malignant cells have concentrated on
the mechanics of adaptive or acquired
immunity, and have in consequence em-
phasized the role of highly specific cell-
mediated or humoral reactions directed
against tumour-specific transplantation
antigens (TSTA). This is however only one
rather limited aspect of immunity, which
overlooks phylogenetically much older
mechanisms responsible for innate resis-
tance.
Hibbs, Lambert and Remington (1972)
have shown that macrophages, when
suitably activated, exert a cytotoxic effect
which discriminates between transformed
and untransformed target cells in vitro,
yet shows no evidence of immunological
specificity. Furthermore, Currie and
Basham (1975) have demonstrated that
malignant target cells can be lysed by a
factor released from activated macro-
phages, whereas the corresponding normal
cells are resistant to lysis. Since Evans
(1972) had shown that many animal
tumours are infiltrated by host macro-
phages and that the extent of infiltration
reflects the biological behaviour of the
tumours, we have been examining the
hypothesis that cells of macrophage-
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monocyte lineage may be significant
limiting factors in host resistance to
tumour growth. Such a role for these cells
would not necessarily be restricted by
immunological specificity in the conven-
tional sense, but may be based on a more
general capacityfordistinguishingbetween
selfand non-self (or normal and abnormal)
such as that seen in invertebrates and in
lower vertebrates.
We have therefore undertaken a series
of studies of monocyte and macrophage
numbers and function in patients with
malignant disease. This first paper de-
scribes experiments designed to count
monocytes in the peripheral blood of
normal individuals and of patients with
malignant melanoma.
Unfortunately the enumeration of
monocytes in the peripheral blood, using
conventional morphological criteria, is
unlikely to be reliable, since subjective
observer error cannot be excluded. A
classical monocyte is readily recognizable
and distinguishable from a classical lym-
phocyte, but in a stained smear of peri-
pheral blood, especially in disease, there
are so many equivocal and intermediate
forms that we felt obliged to abandon
morphology as a diagnostic criterion, aG. A. CURRIE AND D. W. HEDLEY
conclusion similar to that drawn by
Hirsch and Fedorko (1970). In conse-
quence we decided, for the purposes ofthis
study, to define the monocyte in opera-
tional terms asthat mononuclear cell in the
peripheral blood which is capable, under
standard conditions, ofdifferentiating into
a macrophage, i.e. is a macrophage pre-
cursor (MP). For this purpose we have
adapted an assay described by Krikorian
et al. (1975) and have developed a clini-
cally applicable micromethod.
MATERIALS AND METHODS
Patients.-In this study, 34 patients pre-
senting to this hospital with a histologically
proven diagnosis of malignant melanoma
were studied. These were patients with
recurrent, disseminated or inoperable disease.
Blood samples were taken before any treat-
ment was given by us, although several ofthe
patients had undergone previous surgery at
other centres, usually several weeks or even
months before being studied. Fourteen of the
patients had been rendered clinically disease-
free by this earlier surgery but were all ofpoor
prognosis, with a high risk of tumour recur-
rence. Indeed by the time this paper was
written, up to 8 months later, 6 of these 14
had already developed further disease.
Macrophage precursor assay.-Defibrinated
peripheral venous blood was layered on to an
equal volume of a Ficoll-Triosil mixture
(Lymphoprep, Nygaard) and centrifuged as
described by Boyum (1968) for 45 min. The
mononuclear cell band was carefully removed,
counted and washed twice in Medium 199.
This suspension was made up to 2 x 106 cells/
ml in RPM1 1640 (+ 25 mm HEPES and
antibiotics) containing50°% autologous serum,
and was added in 100 ,ul volumes to the wells
of 3040 microplates (Falcon Plastics). The
plates were incubated at 37°C in 2.5% CO2 in
humid air for 7 days. The wells were then
washed free of unattached cells and debris
with three changes of Medium 199, and then
50,U1 of a 091-M citric acid solution containing
1: 2000 crystal violet (Sanford et al., 1951)
was added to each well and the plate was
allowed to stand for 30 min at room tempera-
ture. After vigorous agitation by repeated
aspiration with a 50-pl micro pipette, the
detached nuclei were counted in a haemo-
cytometer. Microscopic examination of the
plates indicated that this procedure removed
all the cell nuclei from the plastic surface.
Each reading represents the mean of at least
5 replicate wells. Theresults were expressed as
a yield of macrophage precursors (MPC) per
ml blood. This was derived as follows:
Mean number of
macrophages/well x Mononuclear cell yield
2 x 105 from 1 ml blood
Preliminary studies had revealed that Ficoll-
Triosil separation methods gave a yield of
over 90% of the mononuclear cells in the
blood. Although occasional polymorpho-
nuclear leucocyte contamination was en-
countered, more often from the patients than
from the normals, their presence did not seem
to inhibit the development of macrophages
in vitro. However, by employing narrow
centrifuge tubes and spinning for at least
45 min, we managed to avoid significant
polymorphonuclear cell contamination in the
studies described.
RESULTS
We examined the influence of many
potential variables on the performance of
this assay before applying it to a series of
patients. Firstly it was found that de-
fibrinated blood always gave higher and
more reproducible results than when using
heparin as an anticoagulant. The presence
of contaminant platelets in cultures ob-
tained from heparinized blood was always
associated with poor or absent macro-
phage development, an observation pre-
viously reported by Krikorian et al. (1975).
Optimal yields were obtained using 50%
autologous serum. Lower concentrations
of autologous serum or 50% foetal calf
serum repeatedly gave much lower and
less reproducible answers. Differential
white counts, using non-specific esterase
staining as a marker for monocytes, indi-
cated that there was no selective loss of
monocytes, attributableeithertodefibrina-
tion or the use ofFicoll-Triosil separation,
in the preparation of cell suspensions from
normal individuals or from the cancer
patients.
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Identity of the Day 7 adherent cell
The cells left attached to the well after
7 days' incubation were, by morpho-
logical criteria, macrophages. However, in
view of previous remarks about morpho-
logical criteria we confirmed their identity
by the following functional criteria. These
cells all had detectable Fc receptors, all
phagocytosed opsonized sheep red cells,
synthesized and released lysozyme and
stained with neutral red. The nuclei of
these cells were also identifiable following
citric-acid-crystal-violet treatment, since
they were reniform and stained a charac-
teristic blue colour. By contrast, lympho-
cyte nuclei when present were smaller,
spherical and stained a readily distinguish-
able shade of pink. There was therefore no
difficulty in identifying lymphocyte con-
tamination and indeed, after 3 washes of
the wells, the level of such lymphocyte
contamination was variable but usually
less than I%.
Reproducibility
Variations from well to well in the yield
of stained nuclei were minimal. Experi-
ments in which 10-20 wells were examined
revealed a total range of values within
100% of the mean value. When wells were
harvested after short incubation times (2
to 3 days) the reproducibility was poor, but
this steadily improved with longer incuba-
tion (7 days) as overt differentiation into
mature spreading macrophages occurred.
There were day-to-day variations in MP
results when single normal donors were
repeatedly tested. However, this variation
was no greater than that ofthe total white
cell count. One normal volunteer (DWH)
was tested on 5 occasions at monthly
intervals, and the results obtained were
6-0, 6-4, 5-7, 6*7 and 7*1 MP x 104/ml.
Furthermore, repeated examination of
MP values in selected patients over shorter
periods showed a similar reproducibility
but at a much lower level of MP.
Do the cells divide in the wells?
Morphologically no evidence of mitosis
or colony formation was seen in the
adherent cells. Furthermore, adherent cell
counts performed at 3, 5, 7 and 9 days
showed no significant increase or decrease
in the number ofnuclei, merely a change in
their size and shape. Cultures were also
washed on Days 3 or 7 and were exposed to
[3H]-thymidine for 16 h using conventional
methods. No significant uptake of [3H]-
thymidine was detected in any of the
cultures tested. We conclude that the
change from monocyte to macrophage
under these assay conditions involves
differentiation but little or no division.
The cells detected in this assay are there-
fore precursors and not progenitors. Multi-
nucleate cells were extremely rare in these
cultures, a finding which indicates that the
nuclear counting method employed was
appropriate. An examination of the num-
ber ofadherent cells in the wells after only
1 h culture indicated that considerably less
than half the adherent cells subsequently
differentiated into macrophages. Further-
more, there appeared to be no correlation
between the number ofadherent cellsat 1h
and the subsequent number of mature
spreading macrophages present at 7 days;
this lack of correlation was especially
marked in the patients. By morphological
examination approximately half the cells
present at 1 h appeared to be lymphocytes.
These cells detached from the plastic over
the first 2 to 3 days of culture.
Linearity
To determine the value of this assay
over a wide range of MP values, we added
serial dilutions ofnormal mononuclear cell
suspensions to the wells, and counted the
number ofmacrophages 7 days later. These
experiments indicated that there is a close
and linear relationship between the num-
ber ofcells added and the MP yield. There-
fore within the range of added cells tested
(i.e. from 5 x 104 to 106 per well) there is
little likelihood of simple mechanical
factors such as overcrowding of cells or
depletion of media leading to unreliable
answers.
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Serumfactors
Since many ofthe patients showed very
depressed MP values (see below), we
examined the possibility that the presence
of inhibitory, or even the absence of
stimulatory, serum factors may be respon-
sible. This was done by incubating mono-
nuclear cells from normal individuals in
serum from melanoma patients and vice
versa. These studies provided no evidence
for suppressive or stimulatory serum
factors. Occasionally, sera did cause a
degree of inhibition, but since these were
found in allogeneic combinations, the
possibility of anti-HLA or even blood
group antibodies cannot be excluded in all
cases. On two occasions, we tested the
effect ofallogeneic patients' sera on mono-
nuclear cells from normal Group 0-ve
donors. As can be seen from the Table,
TABLE.-Macrophage Precursors (x 104/
ml) from Two Normal (0-ve) Donors
(ND) Tested in Autologous Serum and in
Serum from Melanoma Patients (Me)
with MP Values <1 x 104/Ml
Cells from
Serum from ND1 ND2
ND1
ND2
Me 449
Me 475
Me 477
Me 460
Me 513
Me 466
Me 442
6 41
6 70
7 52
4 68
6 23
6 84
6 29
NT
NT
8 40
8 61
8 69
NT
7 92
8 34
8-10
6 42
7*32
sera taken from melanoma patients with
low MP values did not consistently inhibit
the development of macrophages.
MP levels in normal individuals and in
melanoma patients
The assay was performed on blood
obtained from 20 normal healthy donors
(aged 17-60 years) and on 34 patients with
malignant melanoma of similar age range
and sex distribution. The results are
shown in the Figure. In normal donors
there was a wide range of results, with a
mean value of 7-6 ± 4-3 (s.d.) x 104 MP/
ml, whereas the melanoma patients show-
ed much lower levels when compared to
these, i.e. 1.1 ± 1.1 x 104MP/ml. This
dramatic difference seems to indicate that
"final common pathway" malignant mela-
noma is associated with a severe deficiency
in the capacity of peripheral blood mono-
cytes to differentiate into macrophages,
although preliminary studies in other
tumours indicate that such a finding is not
unique to melanoma. Further studies of
patients with non-malignant disease are in
progress.
Monocyte counts and MPs
By conventional morphological methods
using stained smears, the number ofmono-
cytes in the peripheral blood of normal
adults ranged from 200 to 800/mm3. In
these normalindividuals theMP count was
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FIG.-Macrophage precursor levels in 20
normal donors and 34 patients with
malignant melanoma.
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very much lower (i.e. about 33-100/mm3)
and there was no correlation with the
morphological monocyte count. In the
malignant melanoma patients this dis-
crepancy was even greater. Furthermore,
of the 34 untreated patients the absolute
morphological monocyte count was within
the normal range in 24 cases (200-800/
mm3) although the MP count was severely
"subnormal" in most of them.
MPs and clinical stage of the disease
Although the majority of patients with
malignant melanoma seen at this centre
have disseminated, recurrent or inoperable
disease, many are seen who have been
rendered clinically disease-free by prior
surgery but who are likely to recur
rapidly-e.g. patients with metastatic
disease who have been treated by radical
surgical excision. Of the 34 cases studied,
14 fell into this category, i.e. clinically
disease-free but with a high risk of recur-
rence, whereas the remaining 20 cases all
had clinically detectable active disease.
There is, however, no difference in MP
values between these 2 groups. In other
words, the detectable defect in peripheral
blood MP activity is not associated with
overt tumour burden. Prospective studies
to determine the prognostic significance, if
any, of MP levels are in progress in both
the "disease-free at risk" and the overt
disease groups. Furthermore, all the pati-
ents studied were in the "final common
pathway" of their disease. We are there-
fore unable as yet to say whether the MP
defect is restricted to patients with a poor
prognosis.
DISCUSSION
When mononuclear cell suspensions
from normal individuals are cultured
under standard conditions, large numbers
of macrophages develop over a period of
7 days. Similar suspensions obtained from
patients with malignant melanoma pro-
vide only scanty macrophages. This ap-
parent defect in "macrophage precursors"
(MP) can be explained in several ways.
Using conventional morphological criteria,
we found that the patients had peripheral
blood monocyte counts broadly within the
normal range. This observation, con-
firmed by enzyme histochemical methods
(to be published), suggests that an overall
quantitative monocyte defect cannot be
incriminated. However, it is conceivable
that a quantitative defect in a specialized
subset ofmonocytes could beresponsible, a
subset committed to maturation, whose
absence would go undetected by conven-
tional counting methods. Alternatively, a
qualitative explanation involving a gener-
alized defect in monocyte differentiation
could also account for our observations.
Snyderman, Blaylock and Pick (1975)
havereportedthattumoursrelease afactor
which can inhibit accumulation of macro-
phages at inflammatory sites in vivo and
abrogate monocyte chemotaxis in vitro.
However, we have been unable to demon-
strate any consistent effects of patients'
sera, and are therefore led to conclude that
the low MP levels detected in the patients
probably represent an intrinsic cellular
defect in the peripheral blood monocytes
rather than variations in hypothetical
serum factors.
Dizon and Southam (1963), in a study of
skin-window cellular infiltrates, suggested
that patients with "advanced" cancer had
a reduced capacity to mobilize tissue
macrophages. Such a finding could be
explained by the sequestration of mono-
cytes within the growing tumours, as
suggested in an animal model by Eccles
and Alexander (1974). However, studies of
the macrophage content of melanoma
biopsy samples indicate (Currie, 1976) that
significant macrophage infiltration is as-
sociated only with localized disease. Since
the patients examined inthe present study
were those with massive tumour burdens
or with no detectable tumour at all, such a
sequestration hypothesis cannot explain
the apparent deficit of MPs in their
peripheral blood. Furthermore, in their
experimental animal model Eccles and
Alexander (1974) have shown that rats
bearing tumours substantially infiltrated
by host macrophages show defective
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delayed cutaneous hypersensitivity reac-
tions, and they went on to show that this
apparent energy was due to a defect in
macrophage infiltration, i.e. a defect of
inflammation. The nature of this defect,
qualitative or quantitative, was unclear.
However, Eccles, Bandlow and Alexander
(1976) argue that the defect is qualitative,
since they have subsequently shown that
suchapparently anergic rats show asignifi-
cant monocytosis rather than a mono-
cytopenia. Furthermore, Normann and
Sorkin (1976) have confirmedthis observa-
tion in rats bearing DMBA-induced
tumours.
Rhodes (1977) has recently shown that
the peripheral blood monocytes of cancer
patients show an increase in their expres-
sion ofFcreceptors. Ourown recent (asyet
unpublished) studies indicate that several
other monocyte functions (e.g. phago-
cytosis and the lysis of target cells) are
similarly enhanced in patients with malig-
nant melanoma. Defective chemotaxis and
a reduced capacity to mature into macro-
phages seem to be associated with an
increase in other monocyte functions such
as binding to Fc receptors, phagocytosis
and intra cellular killing.
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